Hepatology drugs

1 result
Madrigal Pharmaceuticals, Inc.
Usage: REZDIFFRA is indicated for adults with noncirrhotic nonalcoholic steatohepatitis (NASH) and moderate to advanced liver fibrosis (F2 to F3) as an adjunct to diet and exercise. Approval is based on accelerated evidence of NASH and fibrosis improvement, with further confirmation required for continued usage.